ARTICLE | Company News
Ziconotide NDA accepted for filing
February 29, 2000 8:00 AM UTC
Elan (ELN) said the FDA accepted for filing its NDA for Ziconotide N-type neuronal calcium channel blocker to treat severe chronic pain via the intrathecal route. The compound is under a six-month rev...